Vanguard Group’s ARMO BioSciences, Inc. Common Stock ARMO Stock Holding History

Vanguard Group’s Portfolio ARMO Stock Details ARMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-106,883	Closed	-$4M	–	4146
2018 Q1	$4M	Buy	+106,883	New	+$4.49M	﹤0.01%	3234

Vanguard Group's ARMO Position: Q2 2018 in Review

Vanguard Group sold out of ARMO BioSciences, Inc. Common Stock (ARMO) in Q2 2018, closing a stake of 106,883 shares — an estimated $4M sold.

Vanguard Group first reported a position in ARMO in Q1 2018 and held it in 1 quarter. The position peaked at $4M in Q1 2018. 0 funds tracked by Wall St. Rank hold ARMO as of Q2 2018.

Vanguard Group reported no remaining ARMO BioSciences, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Vanguard Group sold 106,883 ARMO BioSciences, Inc. Common Stock shares in Q2 2018, an estimated $4M.
Vanguard Group first reported a position in ARMO BioSciences, Inc. Common Stock in Q1 2018 and held it in 1 quarter.
Vanguard Group's ARMO BioSciences, Inc. Common Stock position peaked at $4M in Q1 2018.
0 funds tracked by Wall St. Rank held ARMO BioSciences, Inc. Common Stock as of Q2 2018.

Based on Vanguard Group's 13F filing for Q2 2018, filed 14 Aug 2018.